methamphetamine has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kast, RE | 1 |
| Dunnett, SB; Finger, S | 1 |
1 review(s) available for methamphetamine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Use of FDA approved methamphetamine to allow adjunctive use of methylnaltrexone to mediate core anti-growth factor signaling effects in glioblastoma.
Topics: Brain Neoplasms; Central Nervous System Stimulants; Drug Approval; Drug Synergism; Glioblastoma; Humans; Methamphetamine; Naltrexone; Narcotic Antagonists; Neovascularization, Pathologic; Quaternary Ammonium Compounds; United States; United States Food and Drug Administration; Vascular Endothelial Growth Factor A | 2009 |
1 other study(ies) available for methamphetamine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Nimodipine enhances growth and vascularization of neural grafts.
Topics: Animals; Dopamine; Female; Gestational Age; Graft Survival; Hydroxydopamines; Mesencephalon; Methamphetamine; Motor Activity; Neovascularization, Pathologic; Nimodipine; Oxidopamine; Rats; Rats, Inbred Strains; Substantia Nigra; Tegmentum Mesencephali | 1989 |